Our analysis supports the ADA recommendations regarding a Mediterranean diet, glycemic control, and BP control, but we believe the evidence to support aspirin and statin therapy in diabetes is inconclusive. This discordance may be multi-factorial including the exclusion of some relevant studies and an...
Their unequalled efficacy and the difficulty in replacing them with other medications in rheumatology strongly suggest them to be friends rather than foes. However, their long-term use is associated with serious side...V.R. TandonA. MahajanJK Scien...
Both the ADA and KDIGO guidelines underscore the integral role of medical nutritional therapy, including adequate access to nutritional management from a specialty-trained registered dietitian nutritionist (RD/RDN), for optimal diabetes management (Supplementary Table S1). The ADA and KDIGO guidelines bo...
Strengths of this study are its large size and longitudinal follow-up period with detailed clinical data. Also of note, patients in the nonuser group did not receive statin therapy despite guidelines recommending statins, a finding consistent with other studies53that indicate that, in community pra...
normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetalogica 2011;54:2506-14.) and the ad libitum low carbohydrate higher healthy fat ketogenic diet.(Hite AH et al. In the face of contradictory evidence: report of the dietary guidelines for ...
A follow-up to the ACCORD study just published again in the prestigious New England Journal of Medicine reports that blood pressure drugs routinely prescribed to diabeticsincreased the risk of strokes, heart attacks and deaths by 50%— and fibrate/statin cholesterol-lowering therapy failed to reduce...
Within the framework of a multimodal risk management, an optimal antihypertensive therapy of a concomitant elevated blood pressure; a statin therapy in case of elevated LDL cholesterol or regardless of an elevated LDL in proven CVD; ACE inhibitors, angiotensin II receptor blockers, or beta-blockers...
Although there are so many therapeutic measures, most of them are only limited to animal experiments, and more clinical trials or expanded test scope are needed to verify their effectiveness and safety before clinical application so as to provide patients with systematic clinical guidelines. In future...
multifaceted interventions to improve the performance of practitioners and organizational interventions to improve recall and review can enhance the care of diabetes.10 Several clinical trials have been published in recent years that identify patients who are most likely to benefit from statin therapy. Ad...
2016 ESC/EAS Guidelines for the management of dyslipidaemias Eur Heart J, 37 (2016), pp. 2999-3058 CrossrefView in ScopusGoogle Scholar 106 K.C. Maki, P.M. Ridker, W.V. Brown, Grundy S.M., N. Sattar An assessment by the Statin Diabetes Safety Task Force: 2014 update J Clin Lip...